{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:35:03Z","timestamp":1777354503296,"version":"3.51.4"},"reference-count":32,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Recordati Rare Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The high cancer burden in the Middle East and North Africa (MENA region) is coupled with an increasing cancer incidence. While the MENA region constitutes 6% of the world\u2019s population, it remains underrepresented in clinical trials. Cutaneous T-cell lymphomas (CTCLs) represent a heterogeneous group of rare extranodal non-Hodgkin lymphomas with variable clinical presentation. In the MENA region, where darker skin colors are more common than in the West, CTCL generally presents at a younger age and with distinct clinical features that necessitate special expertise and management across disciplines: rare forms of CTCL are more common (hypo- and hyperpigmented MF) and a higher prevalence of pediatric MF is noticed. The multidisciplinary approach to cancer management is growing worldwide and is necessary for the comprehensive management of CTCL. The MENA CTCL group was established with the aim of creating a collaborative environment for the diagnosis and treatment of CTCL in the region. Its first meeting was held in May 2023. The group plans to increase the global representation of the MENA region and establish CTCL registries and patient advocacy groups in the region.<\/jats:p>","DOI":"10.3390\/cancers16193380","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T11:29:24Z","timestamp":1727868564000},"page":"3380","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Landscape of Cutaneous T-Cell Lymphoma (CTCL) in the Middle East and North Africa (MENA) and the Establishment of the MENA CTCL Working Group"],"prefix":"10.3390","volume":"16","author":[{"given":"Rasha","family":"Abdel Tawab","sequence":"first","affiliation":[{"name":"Kuwait Cancer Control Centre, Kuwait City 13001, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihan","family":"Rajy","sequence":"additional","affiliation":[{"name":"As\u2019ad Al Hamad Dermatology Center, Ministry of Health, Kuwait City 13001, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5403-153X","authenticated-orcid":false,"given":"Salah","family":"Abdallat","sequence":"additional","affiliation":[{"name":"Jordan Royal Medical Services, King Hussein Medical Center, Amman 11855, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muna Abdula","family":"Almurrawi","sequence":"additional","affiliation":[{"name":"Dr. Muna Almurrawi Medical Center, Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-7733","authenticated-orcid":false,"given":"Khalil","family":"Al Farsi","sequence":"additional","affiliation":[{"name":"Sultan Qaboos University Hospital, Muscat 123, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4559-1313","authenticated-orcid":false,"given":"Jehad","family":"Alassaf","sequence":"additional","affiliation":[{"name":"Jordan Royal Medical Services, King Hussein Medical Center, Amman 11855, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussni","family":"Alhateeti","sequence":"additional","affiliation":[{"name":"Division of Haematology and Oncology, Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atlal","family":"Al Lafi","sequence":"additional","affiliation":[{"name":"As\u2019ad Al Hamad Dermatology Center, Ministry of Health, Kuwait City 13001, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"El Bahtimi","sequence":"additional","affiliation":[{"name":"International Dermpath Consult, FZ LLC, Dubai, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-1421","authenticated-orcid":false,"given":"Abdulhadi","family":"Jfri","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah 21577, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah 21589, Saudi Arabia"},{"name":"Division of Dermatology, Department of Medicine, Ministry of the National Guard-Health Affairs, Jeddah 21577, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-9432","authenticated-orcid":false,"given":"Chalid","family":"Assaf","sequence":"additional","affiliation":[{"name":"Helios Klinikum Krefeld, 47805 Krefeld, Germany"},{"name":"Institute of Molecular Medicine, Medical School Hamburg, 20457 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"ref_1","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division (2020, December 27). World Population Prospects: The 2017 Revi-sion, Key Findings and Advance Tables; Working Paper No. ESA\/P\/WP\/248; New York, NY, USA, 2017; pp. 2\u20138. Available online: https:\/\/population.un.org\/wpp\/Publications\/Files\/WPP2017_KeyFindings.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Stefan, D.C., and Tang, S. (2023). Addressing cancer care in low- to middle-income countries: A call for sustainable innovations and impactful research. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11272-9"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1016\/S1470-2045(18)30019-6","article-title":"Cancer surveillance in northern Africa, and central and western Asia: Challenges and strategies in support of developing cancer registries","volume":"19","author":"Znaor","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vhri.2023.05.005","article-title":"The Disease Burden and Economic Burden of Cancer in 9 Countries in the Middle East and Africa","volume":"37","author":"Hofmarcher","year":"2023","journal-title":"Value Heal. Reg. Issues"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e13567","DOI":"10.1200\/JCO.2021.39.15_suppl.e13567","article-title":"Oncology clinical research landscape in Middle East and North Africa (MENA) region: Challenges and proposed solutions","volume":"39","author":"Sameh","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Dobos, G., Pohrt, A., Ram-Wolff, C., Lebb\u00e9, C., Bouaziz, J.-D., Battistella, M., Bagot, M., and de Masson, A. (2020). Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients. Cancers, 12.","DOI":"10.3390\/cancers12102921"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/bjd.13849","article-title":"Management of advanced cutaneous T-cell lymphoma: Role of the dermatologist in the multidisciplinary team","volume":"173","author":"Poligone","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.6004\/jnccn.2020.0022","article-title":"NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020","volume":"18","author":"Horwitz","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.2021012057","article-title":"Primary cutaneous lymphoma: Recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2021","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival Outcomes and Prognostic Factors in Mycosis Fungoides\/S\u00e9zary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer Staging Proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113343","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome\u2014Update 2023","volume":"195","author":"Latzka","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_13","first-page":"1360740","article-title":"Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources","volume":"2023","author":"Ibrahim","year":"2023","journal-title":"Dermatol. Res. Pr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0959-8049(21)00688-2","article-title":"Racial differences in clinical presentation and outcomes in mycosis fungoides and S\u00e9zary syndrome in the United States: A large singe center retrospective analysis","volume":"156","author":"Allen","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_15","first-page":"633","article-title":"Racial Disparities in the Clinical Presentation and Prognosis of Patients with Mycosis Fungoides","volume":"111","author":"Huang","year":"2019","journal-title":"J. Natl. Med Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/JDN.0000000000000708","article-title":"Mycosis Fungoides in Skin of Color","volume":"14","author":"Rager","year":"2022","journal-title":"J. Dermatol. Nurses Assoc."},{"key":"ref_17","first-page":"820921","article-title":"Characteristics of Primary Cutaneous T-Cell Lymphoma in Iran: A 10-Year Retrospective Study","volume":"2014","author":"Naeini","year":"2014","journal-title":"Int. Sch. Res. Not."},{"key":"ref_18","first-page":"306543","article-title":"Mycosis Fungoides in Iranian Population: An Epidemiological and Clinicopathological Study","volume":"2015","author":"Naeini","year":"2015","journal-title":"J. Ski. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E259","DOI":"10.1111\/ajd.13192","article-title":"Childhood mycosis fungoides: A clinicopathologic study of 30 cases from Iran","volume":"61","author":"Nasimi","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"ref_20","first-page":"258","article-title":"Mycosis Fungoides in UAE","volume":"6","author":"Hamodat","year":"2021","journal-title":"Saudi J. Pathol. Microbiol."},{"key":"ref_21","first-page":"e21231","article-title":"Clinical Patterns and Treatment Response of Patients with Mycosis Fungoides a Retrospective Study","volume":"14","author":"Alojail","year":"2022","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5144\/0256-4947.2017.212","article-title":"Cutaneous T-cell lymphoma in Saudi Arabia: Retrospective single-center review","volume":"37","author":"Binamer","year":"2017","journal-title":"Ann. Saudi Med."},{"key":"ref_23","first-page":"394","article-title":"Clinicopathologic characteristics and outcomes of patients with mycosis fungoides","volume":"44","author":"Alghubaywi","year":"2023","journal-title":"SciVee"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5001\/omj.2012.28","article-title":"The Histological Spectrum of Early Mycosis Fungoides: A Study of 58 Saudi Arab patients","volume":"27","author":"Arafah","year":"2012","journal-title":"Oman Med. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1007\/s10238-023-01056-7","article-title":"Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: A 29-year review","volume":"23","author":"Titou","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1365-4632.2010.04567.x","article-title":"Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991\u20132006","volume":"49","author":"Alsaleh","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00277-009-0801-z","article-title":"Frequencies of non-Hodgkin\u2019s lymphoma subtypes in Kuwait: Comparisons between different ethnic groups","volume":"89","author":"Ameen","year":"2009","journal-title":"Ann. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1525-1470.2010.01129.x","article-title":"Mycosis Fungoides in Arab Children and Adolescents: A Report of 36 Patients from Kuwait","volume":"27","author":"Nanda","year":"2010","journal-title":"Pediatr. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/DAD.0000000000000379","article-title":"Frequency of Hypopigmented Mycosis Fungoides in Egyptian Patients Presenting with Hypopigmented Lesions of the Trunk","volume":"37","author":"Hassan","year":"2015","journal-title":"Am. J. Dermatopathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.12816\/0047560","article-title":"Clinical and Histopathological Spectrum of Mycosis Fungoides","volume":"40","year":"2018","journal-title":"Bahrain Med. Bull."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Vitiello, P., Sagnelli, C., Ronchi, A., Franco, R., Caccavale, S., Mottola, M., Pastore, F., Argenziano, G., Creta, M., and Calogero, A. (2023). Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides. Healthcare, 11.","DOI":"10.3390\/healthcare11040614"},{"key":"ref_32","first-page":"55","article-title":"Cutaneous T-Cell Lymphoma: Current and Emerging Therapies","volume":"37","author":"Dai","year":"2023","journal-title":"Oncology"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/19\/3380\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:09:35Z","timestamp":1760112575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/19\/3380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":32,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["cancers16193380"],"URL":"https:\/\/doi.org\/10.3390\/cancers16193380","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]}}}